C7A.8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2026 edition of ICD-10-CM C7A.8 became effective on October …

Mar 28, 2019 · NETs are abnormal growths that begin in specialized cells called neuroendocrine cells. The article lists the ICD-10 codes associated with the condition.

C7A.8 is a billable diagnosis code used to specify a medical diagnosis of other malignant neuroendocrine tumors. The code is valid during the current fiscal year for the submission of …

Aug 7, 2025 · Learn about some of the common ICD-10 codes for neuroendocrine tumor diagnoses you can use through this guide.

Nov 9, 2022 · Neuroendocrine tumors (categories C7A, C7B, and D3A) arise from endocrine or neuroendocrine cells scattered throughout the body. The most common sites are the bronchi, …

The code C7A.092 is grouped in the following Diagnostic Related Group (s) MS-DRG V42.0. This ICD-10 to ICD-9 data is based on the 2018 General Equivalency Mapping (GEM) files …

A rare subtype of neuroendocrine neoplasm, arising from enterochromaffin-like cells in the stomach, with a variable clinical presentation, disease course and prognosis, depending on …

Explore detailed ICD-10 coding guidelines for neuroendocrine tumors, including malignant and benign classifications, documentation requirements, and common coding pitfalls.

This resource provides healthcare professionals with essential information for accurate and efficient documentation and coding of NETs. Explore resources related to Neuroendocrine …

C7A is a non-billable ICD-10 code for Malignant neuroendocrine tumors. It should not be used for HIPAA-covered transactions as a more specific code is available to choose from below.